- Retraction Note
- Open access
- Published:
Retraction Note: HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research volume 43, Article number: 246 (2024)
The Original Article was published on 29 October 2015
Retraction Note: J Exp Clin Cancer Res 35, 133 (2015)
The Editor-in-Chief has retracted this article at the corresponding author’s request. After publication, concerns were raised that the data presented in this article appear highly similar to a number of other publications [1,2,3,4,5].
The corresponding author has stated that the experiments were performed by a third party, where the data may have been mismanaged.
Lei Dong agrees to this retraction. None of the other authors have responded to any correspondence from the publisher about this retraction.
References
Wang Y, Ma G, Wang Q, Wen M, Xu Y, He X, Zhang P, Wang Y, Yang T, Zhan P, Wei G. Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cells. Molecules. 2013;19(1):159–76. https://doi.org/10.3390/molecules19010159.
Xia X, Li Y, Wang W, Tang F, Tan J, Sun L, Li Q, Sun L, Tang B, He S. MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway. Mol Cancer. 2015;14:154. https://doi.org/10.1186/s12943-015-0423-0.
Huo X, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation. Oncotarget. 2015;6(39):41959–75. https://doi.org/10.18632/oncotarget.5999.
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G, Wei J. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation. Mol Cancer. 2014;13:137. https://doi.org/10.1186/1476-4598-13-137.
Fan C, Wang Y, Liu Z, Sun Y, Wang X, Wei G, Wei J. Retracted article: Metformin exerts anticancer effects through the inhibition of the sonic hedgehog signaling pathway in breast cancer. Int J Mol Med. 2015;36(1):204–14. https://doi.org/10.3892/ijmm.2015.2217.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-015-0245-3.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lv, X., Li, L., Lv, L. et al. Retraction Note: HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma. J Exp Clin Cancer Res 43, 246 (2024). https://doi.org/10.1186/s13046-024-03171-z
Published:
DOI: https://doi.org/10.1186/s13046-024-03171-z